Entero Healthcare Solutions Limited (NSE:ENTERO)
India · Delayed Price · Currency is INR 1,094.50
-11.00 (-1.00%)
Jun 19, 2026, 1:40 PM IST
NSE:ENTERO Revenue
In the fiscal year ending March 31, 2026, Entero Healthcare Solutions had annual revenue of 65.91B INR with 29.35% growth. Entero Healthcare Solutions had revenue of 19.10B in the quarter ending March 31, 2026, with 42.63% growth.
Revenue
65.91B
Revenue Growth
+29.35%
P/S Ratio
0.73
Revenue / Employee
16.03M
Employees
4,111
Market Cap
48.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 65.91B | 14.95B | 29.35% |
| Mar 31, 2025 | 50.96B | 11.73B | 29.92% |
| Mar 31, 2024 | 39.22B | 6.22B | 18.85% |
| Mar 31, 2023 | 33.00B | 7.78B | 30.85% |
| Mar 31, 2022 | 25.22B | 7.49B | 42.24% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 584.62B |
| Cipla | 278.28B |
| Apollo Hospitals Enterprise | 252.29B |
| Divi's Laboratories | 105.60B |
| Aarti Pharmalabs | 18.19B |
| Innova Captab | 16.30B |
| Artemis Medicare Services | 10.81B |
| Orchid Pharma | 8.11B |
Entero Healthcare Solutions News
- 22 days ago - Entero Healthcare share price target: Jefferies raises target to Rs 1,500 despite mixed quarter - Business Upturn